Tag: visibility
Meta Quest 3: QGO gains international visibility and unlocks the full power of the headset in its latest update!
After a very successful version v9.0.0 which was able to restore the image of Meta Quest 3, the developer Anagan79 comes out a v9.1.0 and unlocks the full potential of…
LDC: Improved half-year results driven by the return to more normal business conditions. Good visibility for the second half. – 11/22/2023 at 5:45 p.m.
LDC press release Improved half-year results driven by the return to more normal business conditionsSolid growth in the first half, gradual return of volumesCurrent operating income of €193.4 million Good…
Inventiva: 43.8 million euros in cash, visibility expected until mid-2024
(AOF) – Inventiva publishes cash and cash equivalents at 43.8 million euros, compared to 86.7 million euros a year ago. The biotech specializing in the clinical development of small molecules…
Inventiva: financial visibility until the 3rd quarter of 2024
By Alexandra Saintpierre Published on 11/21/2023 at 10:24 p.m. Photo credit © Inventiva (Boursier.com) — The turnover ofInventive…
Global Bioenergies: extended financial visibility – 11/16/2023 at 12:33
(CercleFinance.com) – Global Bioenergies gained more than 4% on Thursday on the Paris Stock Exchange after strengthening its cash flow thanks to several collections in the context of public financing.…
Celyad Oncology: cash flow of 2.3 million, visibility until the 1st quarter of 2024 – 09/11/2023 at 1:35 p.m.
(AOF) – Celyad Oncology announces that as of September 30, 2023, it had cash and cash equivalents of 2.3 million euros. The biotech specializing in chimeric antigen receptor T cell…
Poxel: cash flow of 5.3 million euros, visibility until mid-2025 – 08/11/2023 at 6:25 p.m.
(AOF) – Poxel announces that as of September 30, 2023, its cash and cash equivalents amounted to 5.3 million euros. The biotech specialist in innovative treatments against metabolic diseases, including…
Poxel: cash flow of 5.3 million euros, visibility until mid-2025
(AOF) – Poxel announces that as of September 30, 2023, its cash and cash equivalents amounted to 5.3 million euros. The biotech specialist in innovative treatments against metabolic diseases, including…
Transgene: 16.4 million in cash, visibility until the end of 2024
(AOF) – Transgene’s cash, cash equivalents and other current financial assets represent 16.4 million euros as of September 30, 2023, compared to 26.8 million euros as of December 31, 2022.…
TME Pharma: 3 million euros in cash as of June 30, visibility until February 2024 – 10/27/2023 at 6:17 p.m.
(AOF) – “Given cash and cash equivalents of 3 million euros as of June 30, 2023”, TME Pharma “has financial visibility until February 2024”. This is what the biotech specialist…
TME Pharma: 3 million euros in cash as of June 30, visibility until February 2024
(AOF) – “Given cash and cash equivalents of 3 million euros as of June 30, 2023”, TME Pharma “has financial visibility until February 2024”. This is what the biotech specialist…
Adocia: cash flow of 16.8 million euros as of September 30, visibility until the end of July 2024 – 10/25/2023 at 6:25 p.m.
(AOF) – Adocia announces a cash position of 16.8 million euros as of September 30, 2023 “following operations carried out in the third quarter of 2023”. The biotech specialist in…